Also seen on reports as: TC, Serum Cholesterol, Cholesterol (Total)
What is Total Cholesterol?
Total Cholesterol is the sum of all cholesterol-carrying particles in the blood — LDL ('bad' cholesterol), HDL ('good' cholesterol), and the cholesterol carried in VLDL particles. It is sometimes reported as a single test, particularly on basic health checks, when only a summary number is wanted.
On its own, Total Cholesterol is a useful screening number but it tells less of the story than the full lipid profile. Two people with the same Total Cholesterol can have very different cardiovascular risk depending on how the number splits across LDL, HDL, and triglycerides — and the split is what determines treatment decisions.
The test is run on a small blood sample drawn from a vein. NABL-accredited Indian labs report Total Cholesterol in milligrams per decilitre (mg/dL). Total Cholesterol can be measured non-fasting; fasting becomes more important when triglycerides and the full lipid profile are also being measured.
Why doctors order it
Total Cholesterol is part of almost every adult routine health check in India. It is one of the simplest and oldest cardiovascular-risk markers and is often the first lipid number people see on their reports.
It is also the input for several cardiovascular risk calculators (Framingham, ASCVD risk score, WHO/ISH chart), which combine Total Cholesterol with age, sex, blood pressure, smoking status, and diabetes status to estimate 10-year heart-disease risk.
Doctors order it specifically in pre-employment medicals, antenatal panels, and basic corporate health bundles where the full lipid profile may not be included. In follow-up of known dyslipidaemia or on lipid-lowering treatment, the full lipid profile is preferred over Total Cholesterol alone.
What the result means
Total Cholesterol below 200 mg/dL is generally considered desirable in the population at average risk. Values between 200–239 mg/dL are 'borderline high', and ≥240 mg/dL is 'high'. These categories were designed for screening, not for treatment decisions, which are usually made against LDL targets and overall cardiovascular risk.
A 'normal' Total Cholesterol can hide a problem if HDL is low and LDL is high — common in the Asian-Indian dyslipidaemia pattern. Conversely, a high Total Cholesterol with very high HDL (and proportionally lower LDL) is less concerning than the same Total Cholesterol with low HDL. This is why doctors usually order the full lipid profile rather than relying on Total Cholesterol alone.
For everyday interpretation, the Non-HDL Cholesterol — calculated as Total Cholesterol minus HDL — is more closely linked to cardiovascular risk than Total Cholesterol itself. Many Indian labs now report Non-HDL alongside the full panel for this reason.
Reference range
Values in mg/dL — screening categories for the general population
- Desirable
- Below 200 mg/dL
- Borderline high
- 200 – 239 mg/dL
- High
- 240 mg/dL or higher
- Non-HDL Cholesterol (Total minus HDL)
- More closely tied to risk than Total Cholesterol alone
These categories are population-level screening cut-offs — not treatment targets. Treatment decisions are made against the full lipid profile (especially LDL) and overall cardiovascular risk. A 'normal' Total Cholesterol can still hide a high LDL with low HDL.
Common factors that affect the result
The same factors that drive the full lipid profile also drive Total Cholesterol — diet (saturated fat, trans-fat, dairy fat, refined carbohydrates), body weight, physical activity, smoking, alcohol intake, and underlying metabolic conditions (diabetes, hypothyroidism, chronic kidney disease, nephrotic syndrome).
Some medications raise Total Cholesterol — steroids, certain retinoids (acne medications), some immunosuppressants, and rarely oral contraceptives. Statins, fibrates, ezetimibe, and bile-acid binders lower it. Thyroid hormone replacement in untreated hypothyroidism often lowers Total Cholesterol meaningfully.
Acute illness, severe infection, and major surgery temporarily lower Total Cholesterol — sometimes substantially. For a true baseline, lipid testing is usually delayed until at least 2–4 weeks after an acute event.
When to talk to your doctor
- Your Total Cholesterol is above 240 mg/dL — this usually warrants a full lipid profile and risk assessment rather than treatment based on Total Cholesterol alone.
- Your Total Cholesterol is between 200 and 239 mg/dL and you have risk factors — diabetes, hypertension, central obesity, smoking, family history of early heart disease.
- You have not yet had a full lipid profile and your Total Cholesterol is on the higher side — the LDL/HDL/TG split is what most influences treatment decisions.
- You are starting or stopping a lipid-lowering medication and Total Cholesterol is being tracked alongside the full lipid profile.
- Your Total Cholesterol has dropped suddenly, particularly during illness — doctors usually retest at baseline after recovery rather than acting on a sick-state low reading.
Related tests
Sources
- Lipid Association of India (LAI) Expert Consensus Statement on Management of Dyslipidaemia — Lipid Association of India
- Cardiological Society of India (CSI) Position Papers — Cardiological Society of India
- ACC/AHA Guideline on the Management of Blood Cholesterol — American College of Cardiology / American Heart Association
- WHO Cardiovascular Disease Risk Assessment Charts — World Health Organization
See our medical disclaimer for what this content is and is not.